AURELUX 77

K972946 · Aurex Precious Metal Industries (Pty)Ltd · EJT · Dec 19, 1997 · Dental

Device Facts

Record IDK972946
Device NameAURELUX 77
ApplicantAurex Precious Metal Industries (Pty)Ltd
Product CodeEJT · Dental
Decision DateDec 19, 1997
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 872.3060
Device ClassClass 2

Intended Use

Dental casting alloy used in combination with dental ceramics for fabrication of metallo-ceramic restoration.

Device Story

Aurelux 77 is a high-gold dental casting alloy used by dental technicians to fabricate metallo-ceramic restorations. The alloy is cast in a dental laboratory setting to create the metal substructure for porcelain-veneered crowns or bridges. It serves as a biocompatible base material that supports dental ceramics. The device is provided as a raw material for casting; it does not involve electronic inputs, software, or automated processing. Its clinical benefit is the provision of a durable, biocompatible metal framework for dental prosthetics.

Clinical Evidence

Bench testing only. Physical and mechanical properties (melting point, hardness, yield strength, elongation, CTE, density) were compared against the predicate device. Biocompatibility is supported by the high noble metal content (>95%).

Technological Characteristics

High-gold casting alloy. Composition: Au 76.6%, Pt 9.9%, Pd 9.3%, Ag 1.2%, Sn 0.6%, Cu 0.5%, In 1.5%, Fe 0.2%. Testing standards: ANSI/ADA 5 and ISO 9693. Form factor: casting alloy for dental laboratory use.

Indications for Use

Indicated for patients requiring metallo-ceramic dental restorations; used by dental professionals for fabrication of dental prosthetics.

Regulatory Classification

Identification

A noble metal alloy is a device composed primarily of noble metals, such as gold, palladium, platinum, or silver, that is intended for use in the fabrication of cast or porcelain-fused-to-metal crown and bridge restorations.

Special Controls

*Classification.* Class II (special controls). The special control for these devices is FDA's “Class II Special Controls Guidance Document: Dental Noble Metal Alloys.” The devices are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 872.9. See § 872.1(e) for availability of guidance information.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows a logo with the word "AUREX" in bold, capitalized letters. Above the word is a black geometric shape that resembles two overlapping triangles or mountains. A horizontal line underlines the word "AUREX", emphasizing the brand name. P.O. Box 509 Edenvale 1610 Republic of South Africa Telephone : +27 (11) 609-8640 Telefax : +27 (11) 452-3918 K972946 # 510 (k) Summary AURELUX 77 Trade name: Common name: Dental casting alloy Gold based alloys and precious metal alloys for clinical use Classification name: Class ification number: EJT Legally marketed device: Jelenko Jel 96 Description of the device: High gold casting alloy Intended use of the device: Type IV restorations with porcelain veneering ## Summary of the technological characteristics Test methods applied: as in ANSI/ADA 5 and ISO 9693 Comparison of composition: | ALLOY | | COMPOSITION (weight%) | | | | | | | | | |-------|------------|-----------------------|-----|-----|-----|-----|-----|-----|------|----| | | Name | Au | Ag | Pt | Pd | Cu | Fe | Sn | In | Ir | | Legal | Jel 96 | 78 | 1.2 | 6 | 12 | 4.5 | 1 | x | x | x | | New | Aurelux 77 | 76.6 | 1.2 | 9.9 | 9.3 | 0.5 | 0.2 | 0.6 | .1.5 | 0. | x is less than 1 % Comparison of physical and mechanical properties | ALLOY | Melting point range (°C) | | Hardness (Vickers 5/30) | | Yield strength (MPa) | | Elongation (%) | | CTE (x10-6/°C) | Density (g/cm3) | |----------------|--------------------------|--------|-------------------------|------|----------------------|------|----------------|------|----------------|-----------------| | Name | solid. | liquid | soft | hard | soft | hard | soft | hard | | | | Legal Jel 96 | 1170 | 1260 | | 255 | | 655 | | 4 | 14.5 | 17.2 | | New Aurelux 77 | 1150 | 1230 | 200 | 245 | 350 | 650 | 19 | 11 | 14.1 | 18.5 | #### Discussion With the exception of a very small copper content the two alloys have almost identical composition and properties. The noble metal content in both alloys is higher than 95 %. Less than 1 % difference in base metal concentration. ### Conclusion The major constituent (Au) and the noble metal content are similar. Even the residuals are the same elements. The very high noble metal content suggest an effective biocompatibility Image /page/0/Picture/22 description: The image shows a logo with the text "TUV CERT" stacked on top of each other. The logo is enclosed in a rectangular box with rounded corners. There are two curved lines above the text, and the text "ISO 9001" is below the text. -11- {1}------------------------------------------------ : DEC 1 9 1997 Image /page/1/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the caduceus symbol. The logo is black and white. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Jerome D. Davis Managing Director Aurex Precious Metal Industries (Pty) Ltd. P.O. Box 509 Edenvale 1610 Republic of South Africa K972946 Re : Trade Name: Aurelux 77 Requlatory Class: II Product Code: EJT October 6, 1997 Dated: Received: October 17, 1997 Dear Mr. Davis: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual reqistration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Requlation (QS) for Medical General regulation (21 CFR Part 820) and that, Devices: through periodic (QS) inspections, the Food and Druq Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you miqht have under sections 531 {2}------------------------------------------------ Page 2 - Mr. Davis through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Timothy A. Ulatowski Timothy A. Ulatowski Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows a logo with the word "AUREX" in bold, capitalized letters. Above the word is a black geometric shape that resembles two overlapping triangles or mountains. A horizontal line underlines the word "AUREX", emphasizing the brand name. P.O. Box 509 Edenvale 1610 Republic of South Africa Telephone : +27 (11) 609-8640 Telefax : +27 (11) 452-3918 K972946 # 510 (k) Summary AURELUX 77 Trade name: Common name: Dental casting alloy Gold based alloys and precious metal alloys for clinical use Classification name: Class ification number: EJT Legally marketed device: Jelenko Jel 96 Description of the device: High gold casting alloy Intended use of the device: Type IV restorations with porcelain veneering ## Summary of the technological characteristics Test methods applied: as in ANSI/ADA 5 and ISO 9693 Comparison of composition: | ALLOY | | COMPOSITION (weight%) | | | | | | | | | |-------|------------|-----------------------|-----|-----|-----|-----|-----|-----|------|----| | | Name | Au | Ag | Pt | Pd | Cu | Fe | Sn | In | Ir | | Legal | Jel 96 | 78 | 1.2 | 6 | 12 | 4.5 | 1 | x | x | x | | New | Aurelux 77 | 76.6 | 1.2 | 9.9 | 9.3 | 0.5 | 0.2 | 0.6 | .1.5 | 0. | x is less than 1 % Comparison of physical and mechanical properties | ALLOY | Melting point range (°C) | | Hardness (Vickers 5/30) | | Yield strength (MPa) | | Elongation (%) | | CTE (x10-6/°C) | Density (g/cm3) | |----------------|--------------------------|--------|-------------------------|------|----------------------|------|----------------|------|----------------|-----------------| | Name | solid. | liquid | soft | hard | soft | hard | soft | hard | | | | Legal Jel 96 | 1170 | 1260 | | 255 | | 655 | | 4 | 14.5 | 17.2 | | New Aurelux 77 | 1150 | 1230 | 200 | 245 | 350 | 650 | 19 | 11 | 14.1 | 18.5 | #### Discussion With the exception of a very small copper content the two alloys have almost identical composition and properties. The noble metal content in both alloys is higher than 95 %. Less than 1 % difference in base metal concentration. ### Conclusion The major constituent (Au) and the noble metal content are similar. Even the residuals are the same elements. The very high noble metal content suggest an effective biocompatibility Image /page/3/Picture/22 description: The image shows a logo with the text "TUV CERT" stacked on top of each other. The logo is enclosed in a rectangular box with rounded corners. There are two curved lines above the text, and the text "ISO 9001" is below the text. -11- {4}------------------------------------------------ : DEC 1 9 1997 Image /page/4/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the caduceus symbol. The logo is black and white. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Jerome D. Davis Managing Director Aurex Precious Metal Industries (Pty) Ltd. P.O. Box 509 Edenvale 1610 Republic of South Africa K972946 Re : Trade Name: Aurelux 77 Requlatory Class: II Product Code: EJT October 6, 1997 Dated: Received: October 17, 1997 Dear Mr. Davis: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual reqistration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Requlation (QS) for Medical General regulation (21 CFR Part 820) and that, Devices: through periodic (QS) inspections, the Food and Druq Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you miqht have under sections 531 {5}------------------------------------------------ Page 2 - Mr. Davis through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Timothy A. Ulatowski Timothy A. Ulatowski Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {6}------------------------------------------------ 510(k) Number (if known): Device Name: _________________________________________________________________________________________________________________________________________________________________ 77 Indications For Use: Dental casting alloy used in combination with dental ceramics for fabrication of metallo-ceramic restoration. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Susan Runoe (Division Sign-Off) Division of Den and General H 510(k) Numb Prescription Use `er 21 CFR 801.109) OR Over-The-Counter Use (Optional Format 1-2-96)
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%